ArticleProceedings of the National Academy of Sciences of the United States of America2026
Electrochemical lateral flow assay with ELISA-level performance for detecting plant diseases in East Africa.
Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Cassava brown streak disease (CBSD) threatens food security for millions in East Africa, yet its control remains limited by the absence of field-deployable molecular diagnostics. Here, we introduce ELLA (Electrochemical Lateral flow assay with Linked Analytics), a battery-free, smartphone-powered electrochemical lateral flow assay that delivers enzyme-linked immunosorbent assay (ELISA)-grade protein detection directly in the field. ELLA integrates near-field communication, a single-chip potentiostat, metal-pin electrodes, and ferrocene-labeled nanoparticles into a fully disposable cassette, enabling quantitative immunoassays without optical instrumentation or centralized laboratory infrastructure. Validated across laboratory studies and extensive field trials in Tanzania, ELLA achieved 95% agreement with ELISA and 89% agreement with RT-qPCR, outperforming ELISA's limit of detection while maintaining a material cost below US$1. By coupling molecular test results with cloud-linked analytics, we further trained DeepELLA, a smartphone-based image classification model that enables scalable surveillance from field-acquired leaf images. Together, these advances unify electrochemical sensing, digital connectivity, and AI-assisted interpretation, enabling portable, ELISA-level diagnostics for plant, environmental, and health monitoring in resource-limited regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.